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Abstract
Background: Real-time perfusion (RTP) contrast echocardiography can be used during adenosine
stress echocardiography (ASE) to evaluate myocardial ischemia. We compared two different types
of RTP power modulation techniques, angiomode (AM) and high-resolution grayscale (HR), with
99mTc-tetrofosmin single-photon emission computed tomography (SPECT) for the detection of
myocardial ischemia.
Methods: Patients with known or suspected coronary artery disease (CAD), admitted to SPECT,
were prospectively invited to participate. Patients underwent RTP imaging (SONOS 5500) using
AM and HR during Sonovue® infusion, before and throughout the adenosine stress, also used for
SPECT. Analysis of myocardial perfusion and wall motion by RTP-ASE were done for AM and HR
at different time points, blinded to one another and to SPECT. Each segment was attributed to one
of the three main coronary vessel areas of interest.
Results: In 50 patients, 150 coronary areas were analyzed by SPECT and RTP-ASE AM and HR.
SPECT showed evidence of ischemia in 13 out of 50 patients. There was no significant difference
between AM and HR in detecting ischemia (p = 0.08). The agreement for AM and HR, compared
to SPECT, was 93% and 96%, with Kappa values of 0.67 and 0.75, respectively (p < 0.001).
Conclusion: There was no significant difference between AM and HR in correctly detecting
myocardial ischemia as judged by SPECT. This suggests that different types of RTP modalities give
comparable data during RTP-ASE in patients with known or suspected CAD.
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Background
Patients with suspected myocardial ischemia are often
assessed using different types of exercise tests for ischemic
evaluation, according to current clinical guidelines [1,2].
Exercise ECG is considered the first-line technique for
assessment of ischaemia, whereas single-photon emission
computed tomography (SPECT) or dobutamine atropine
stress echocardiography (DSE) are suggested when exer-
cise ECG are non-diagnostic or non-interpretable [3,4].
Both SPECT and DSE are more accurate methods than
exercise ECG, although more expensive [4-7].
Adenosine stress echocardiography (ASE) is a less expen-
sive technique as compared to SPECT and more tolerable
compared to DSE for the assessment of patients with sus-
pected coronary artery disease. However, ASE, using only
wall motion evaluation, is less accurate for the detection
of myocardial ischemia as compared to DSE and SPECT.
[8-10]. The use of second-generation contrast agents in
myocardial contrast echocardiography enables assess-
ment of myocardial perfusion during ECG triggered image
acquisition echocardiography with high mechanical
index, i.e. harmonic power Doppler. This technique is not
only technically demanding, but also has limitations, e.g.
because no wall motion evaluation is possible.
Real-time myocardial perfusion echocardiography (RTP)
has recently been developed using highly contrast specific,
low mechanical index imaging techniques. RTP during
intravenous infusion of a second-generation contrast
agent allows for simultaneous analysis of myocardial per-
fusion and wall motion. Earlier studies with RTP have
shown promising results for the evaluation of myocardial
perfusion [11-18]. However, there is limited clinical data
on the accuracy of RTP-ASE for the detection of myocar-
dial ischemia in unselected patient groups. The RTP tech-
niques continue to evolve and new improvements are
developed continuously. There are, however, only few
studies carried out to find out if the new developments
really improve the evaluation of ischemia.
Adenosine is a sub-optimal stressor for wall motion anal-
ysis and may be less sensitive in detecting ischemia [3].
On the other hand, perfusion defects seem to be more vis-
ible with adenosine compared to dobutamine [9]. The
myocardial contrast echocardiography technique is still
burdened with perfusion artifacts and echocardiographic
shadowing, which limit the number of interpretable myo-
cardial segments. These segments can in most cases, using
RTP, still be interpreted with wall motion analysis, which
therefore increases the usefulness of RTP-ASE without
diminishing accuracy considerably [15]. Thus, combining
perfusion and wall motion assessment, RTP-ASE has the
potential of being as accurate and feasible as DSE and
SPECT, and may be a swift, bedside-accessible, useful
decision-making tool for risk assessment of patients with
suspected myocardial ischemia.
Two techniques of RTP power modulation have been
developed. The first technique available was angio-mode
(AM), in which echoes from contrast bubbles are dis-
played as colored pixels in the two dimensional images
and are, therefore, easily differentiated from the tissue
echoes, which are displayed in grey scale. The most
recently developed power modulation technique is the
high-resolution grey scale (HR). Using HR, the only ech-
oes displayed are grey scale echoes from contrast bubbles.
The HR technique is meant to suppress all echoes origi-
nated from tissue and has a higher spatial resolution com-
pared to AM. The difference between the two techniques
has to our knowledge not been examined by head to head
comparison.
The aim of the present study was to compare the two
power modulation techniques, AM and HR, during RTP-
ASE, for the detection of myocardial ischemia, as judged
by 99mTc-tetrofosmin SPECT, in a clinical patient popula-
tion with known or suspected myocardial ischemia.
Methods
Patient population
The patient population consisted of 51 randomly selected
patients with known or suspected coronary artery disease,
admitted to SPECT evaluation, to participate in the study.
The patient's acoustic windows were not screened prior to
inclusion. One of the included patients had non-inter-
pretable echocardiography images, both regarding wall
motion and perfusion, and was therefore excluded from
the study. The institutional ethics committee of the Lund
University, Sweden, approved the study (Lu 113-03).
Written informed consent was obtained from all partici-
pating patients.
Study protocol
Myocardial contrast echocardiography
The echocardiographic equipment used was a Sonos 5500
(Philips, Andover, MA, USA) with S3 probe and RTP using
power modulation AM and HR. Patients were examined
in a left lateral recumbent position. The second-genera-
tion contrast agent Sonovue® was infused in the left decu-
bital vein using an infusion pump dedicated for this
purpose (VueJect® Esaote, Genova, Italy; Bracco™, Milano,
Italy), which automatically rotates the syringe to prevent
sedimentation. The infusion rate of Sonovue® was set
between 1.0 and 1.3 ml/min [19]. Adenosine and echo
contrast were infused in the same peripheral venous cath-
eter, using a separate infusion pump through a three-way
stopcock. Adenosine was given at an infusion rate of 100
μg/kg/min during one minute, and was thereafter
increased to 140 μg/kg/min.Cardiovascular Ultrasound 2009, 7:19 http://www.cardiovascularultrasound.com/content/7/1/19
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All 50 patients underwent RTP imaging (mechanical index
= 0.1) during infusion of echo contrast, at rest and after a
minimum of one minute of hyperemia during adenosine
stress (at 140 μg/kg/min). Image acquisition was started
after a minimum time of one minute of Sonovue® infusion.
RTP image loops containing 8–10 heartbeats were collected
from the parasternal long- and short-axis and apical four-
and two-chamber views, respectively. At the beginning of
each loop a destruction impulse of 10 high mechanical
index frames (mechanical index = 1.5) were given to
destroy all contrast micro bubbles in the myocardium [20].
During RTP AM, the angio-mode gain was set at between
60 and 70%, depending on what was suitable for the indi-
vidual patient as judged by a visual on-line assessment,
and 2D grayscale gain was set at zero. During RTP HR the
grey-scale gain was set between 90 and 95%, depending
on what was suitable for the individual patient, as judged
by a visual on-line assessment. Focus was set close to the
base of the left ventricle. All images were stored digitally
for later off-line analysis.
SPECT
The rest and stress studies were performed using a 2-day
protocol, starting with injection of 600 MBq 99mTc-tetro-
fosmin at stress. Stress was simultaneous with the RTP-
ASE. Normal findings at stress were not followed by a rest
study [21,22]. Pathological stress studies were followed by
a rest study with injection of 800 MBq 99mTc-tetrofosmin.
A five-minute adenosine infusion protocol was used.
Patients who had cardiac medications, which could inter-
fere with the stress test, were informed to have their med-
ication interrupted prior to the stress test. The decision
whether to interrupt the drug administration was at the
discretion of the referring physician. Starting the infusion
with 100 μg/ml/min of adenosine for 1 minute, the dose
was then increased to 140 μg/ml/min for two minutes
before injecting 99mTc-tetrofosmin. Infusion of adenosine
was continued for 2 min after the injection of 99mTc-tetro-
fosmin. The scintigraphic data were acquired one hour
after the end of the stress test, using continuous SPECT
over 180 degree elliptical rotation from the 45 degree
right anterior oblique position, with a dual-head gamma
camera (Siemens AG Medical Solutions, Erlangen, Ger-
many). Low energy high-resolution collimator and a
zoom factor of 1.0 were used. We obtained 64 projections
in a 128 × 128 matrix, with an acquisition time of 20 s per
projection. Tomographic reconstruction and calculation
of short axis slice images were performed using Siemens
software. A two-dimensional Butterworth pre-reconstruc-
tion filter was used with critical frequency of 0.35, order
5. For each patient, the same sets of short axis slices were
then processed with an automatic software package (4D-
MSPECT) on a Siemens e.soft workstation. The software
package defined apex and base and generated, coronal,
longitudinal, sagital tomographic slices as well as polar
maps with schematic map of the territories of the main
coronary arteries used for scoring. Radiotracer uptake of
the vascular segments was scored visually and stress
images were compared with rest images regarding
ischemia and infarct. The specialist in nuclear medicine
who performed the scoring was blinded to the results of
the RTP analysis.
RTP-ASE image interpretation
Image interpretation was performed off line, analyzing
myocardial perfusion and wall motion by RTP-ASE, using
the EnConcert Image Diagnosis Application (Philips,
Andover, MA, USA). A separate analysis exclusively of per-
fusion was also made for both AM and HR to estimate the
value of sole perfusion analysis. AM and HR were evalu-
ated on separate occasions blinded to one another and
blinded to the result of the SPECT interpretation.
Each segment was attributed to one of the three main cor-
onary vessel areas of interest; the left anterior descending
(LAD); the left circumflex (LCx); and the right posterior
descending (RPD) (see Figure 1). Myocardial ischemia
was visually evaluated comparing rest and stress images,
using both perfusion and wall motion analysis in a com-
plementary manner. A visually detected perfusion defect
during stress was used as the principal marker of ischemia.
Thus, a myocardial segment was considered ischemic if
perfusion was impaired in the stress images, compared to
the rest images [9]. Perfusion defects were analyzed at the
earliest four beats following the destruction impulse at
rest and after two beats at peak stress.
Wall motion was used in addition to reveal perfusion
defect artifacts at rest and to evaluate segments with sus-
pected perfusion artifacts at stress. Since wall motion
should not be normal if a segment has a true perfusion
defect at rest, a perfusion defect at rest was considered to
be an artifact when wall motion was normal in that seg-
ment. A perfusion defect at peak stress was considered to
be an artifact if there was a suspicion of a perfusion arti-
fact, such as lateral or anterior shadowing from ribs or
lungs, or basal segments shadowed by contrast. In such
segments, the ischemic evaluation was based on wall
motion analysis alone. If wall motion decreased at stress
compared to rest images, the segment was considered
ischemic. Since perfusion can be decreased without a
decrease in wall motion in ASE, the use of solitary wall
motion analysis in segments with perfusion artifacts
might decrease the sensitivity with regard to ischemia.
However, this complementary use of wall motion analysis
increases the number of interpretable segments without
negatively affecting specificity [11].
Statistical analysis
Power calculation for the RTP-ASE comparison to SPECT
was based on a sensitivity and specificity between 80 andCardiovascular Ultrasound 2009, 7:19 http://www.cardiovascularultrasound.com/content/7/1/19
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90% of the methods used. We assumed a sensitivity and a
specificity of 85% in the study. With 50 patients we would
have a 95% confidence interval of ± 10% around sensitiv-
ity and specificity. The SPSS® (Version 12.0.1, Chicago, IL,
USA) statistical program was used for the statistical analy-
sis. We calculated sensitivity and specificity, positive and
negative predictive values (PPV, NPV), as well as accuracy
and Kappa values in the three predefined distribution
areas of the three main coronary vessels. To assess differ-
ences between AM and HR, the chi-squared test was per-
formed. Method of reference for the ischemia evaluation
in the study was the presence or absence of reversible
ischemia in the SPECT examination. Results are expressed
as mean ± SD and as percent. P < 0.05 denoted signifi-
cance.
Results
Baseline characteristics including clinical data extracted
from patient's records are shown in Table 1. Mean age of
the 50 patients was 70 years, two thirds were women and
mean left ventricular ejection fraction was close to nor-
mal. A history of previous myocardial infarction was
found in less than half of the patients, around one third
had undergone previous coronary intervention, a major-
ity had no previous hospitalization or intervention due to
coronary artery disease, and around one fifth of the
patients had no cardiac medication. At SPECT, 13 (26%)
of the patients were ischemic in at least one coronary area.
Of 150 coronary areas assessed, all were considered inter-
pretable and were analyzed both using SPECT and RTP
with AM and HR. The overall level of agreement between
RTP-ASE and SPECT in detecting ischemia was 93% for
AM and 96% for HR. The chi-square test for difference
between AM and HR in correctly judging ischemia was
borderline-significant (p = 0.08). The Kappa values were
0.67 for AM and 0.75 for HR (p < 0.001). Accuracy, sensi-
tivity, specificity, predictive values and Kappa values for
the detection of myocardial ischemia of RTP-ASE AM and
HR, in the respective coronary areas, compared to SPECT
are shown in Table 2. HR generally showed somewhat
higher values for kappa, accuracy, positive prediction and
specificity, whereas AM showed higher sensitivity values.
The NPVs were similar. The same comparative values for
the sole perfusion interpretation concerning AM and HR
compared to SPECT are displayed in Table 3, demonstrat-
ing differences similar to the combined perfusion and
wall motion analysis. Accuracy and Kappa values for the
agreement between AM and HR are shown in Table 4,
indicating lesser agreement between AM and HR than for
their respective comparison with SPECT. Figure 2 repre-
sents a graph of accuracy between different modalities of
RTP-ASE versus SPECT.
In Table 5, the numbers of non-interpretable coronary
areas are presented. In the sole perfusion analysis the
numbers include coronary areas considered to be per-
fusion artifacts. There is evidence of similar loss of inter-
pretable coronary areas for both AM and HR.
Inter- and intra-observer agreements for the interpretation
of ischemia according to the RTP-ASE AM and HR exami-
nations are presented in Table 6.
A movie of RTP-ASE images of a perfusion defect at stress
is presented [see Additional file 1].
Discussion
The results from the present study show overall similari-
ties, but some differences, although no statistically signif-
icant, between the two different types of RTP power
modulation techniques, thus data derived from different
techniques for RTP-ASE are reasonably interchangeable.
As judged by SPECT, there were highly significant agree-
ments for both AM and HR in detecting ischemia. The
finding that RTP can be used to accurately detect ischemia
is in line with previous investigations [11-15,17,18].
Although there were no significant differences between
AM and HR in agreement, there were some differences
worth discussing.
Both methods showed high NPVs, which is of importance
for correctly acquitting ischemia in patients. The NPV is
especially important in this study cohort, since the preva-
lence of reversible ischemia was quite high (26%). Conse-
quently, the value of PPV becomes relatively less
important in this study. Wall motion abnormalities were
present in 60% of the patients, indicating a very high prev-
alence of ischemic heart disease. However, the objective
was to assess the accurate detection of reversible ischemia
Distribution territories of the three main coronary arteries Figure 1
Distribution territories of the three main coronary 
arteries. Distribution territories of the three main coronary 
arteries in a 17 segment model. Left anterior descending 
(LAD), left circumflex (LCx) and right coronary artery 
(RCA).Cardiovascular Ultrasound 2009, 7:19 http://www.cardiovascularultrasound.com/content/7/1/19
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using AM and HR respectively, not to reveal the presence
or absence of ischemic heart disease. Hence, any differ-
ence between AM and HR regarding PPVs becomes less
important. Using SPECT as reference, HR showed higher
values of kappa and accuracy, suggesting that HR is better
suited than AM in this kind of population, i.e. with high
pre-test probability of reversible myocardial ischemia. On
the other hand, AM seems to have somewhat slightly
higher sensitivity, which means that the risk of a false neg-
ative test values could actually be higher for HR. Sensitiv-
ity and specificity are somewhat connected to PPV and
NPV, respectively, but are less affected by the prevalence
of ischemia in the actual patient sample examined. Sensi-
tivity and specificity values may, therefore, provide more
reliable information about the precision of the test, rather
than about the health of the patients. The finding that sen-
sitivity figures were higher for AM than for HR indicates
that AM RTP-ASE may be better at detecting the true
reversibly ischemic patient, while the higher specificity
values for HR might represent better identification of non-
ischemic patients, as judged by SPECT. The slightly better
sensitivity for AM might be due to the potentially easier
visual assessment, to some point since echoes from con-
trast bubbles are displayed as colored pixels, in distinction
to HR, where echoes are displayed in grey scale, but prob-
ably to a greater extent due to the lower resolution in AM.
The lower resolution enables possible higher sensitivity
because larger pixels provide more echo signal per pixel to
process (higher statistical power) and thus a enhanced sig-
nal-to-noise ratio.
The higher kappa and accuracy values could therefore be
due to superiority in correctly detecting non-ischemic ter-
ritories, which were predominating in the present study
population. The similarities and differences between AM
and HR were approximately similar in the sole perfusion
analysis, as compared with the combined perfusion and
wall motion analysis. This indicates that agreement with
SPECT can be maintained using wall motion analysis in
coronary areas with perfusion artifacts, as previously sug-
gested [15]. This should be viewed in relation to the
results of non-interpretable coronary areas; where the
high number of non-interpretable coronary areas in the
sole perfusion analysis clearly illustrates lower feasibility,
compared to the combined perfusion and wall motion
Table 1: Patients characteristics, including clinical data extracted 
from patient's records.
Age 70 (± 8)
Male 36%
LVEF at rest 55 (± 9) %
Previous AMI 40%
Previous PCI 22%
Previous CABG 16%
Heart failure 12%
Hypertension 54%
Valvular surgery 0%
Beta-blocker 54%
ACE inhibitor 28%
ARB 14%
Nitro-glycerin (short acting) 60%
Nitrates (long acting) 28%
Diuretics 29%
Calcium blocker 24%
Sinus rhythm 92%
Dilated left ventricle 10%
Dilated left atrium (n = 29) 31%
Significant valvular disease (n = 31) 6%
Regional WMA/PD at rest 60%
LVEF, left ventricular ejection fraction; AMI, acute myocardial 
infarction; PCI, percutaneous coronary intervention, CABG, coronary 
artery bypass grafting; ACE, angiotensin converting enzyme; ARB, 
angiotensin-receptor blocker, WMA, wall motion abnormality; PD, 
perfusion defect.
Table 2: RTP-ASE angio-mode (AM) versus high resolution (HR) with combined perfusion and wall motion analysis.
All CA
(n = 150)
Patient
(n = 50)
LAD
(n = 50)
LCx
(n = 50)
RPD
(n = 50)
AM Accuracy (%) 93 88 88 94 98
AM PPV (%) 57 71 54 50 100
AM N P V  ( % ) 9 9 9 71 0 0 1 0 09 8
AM Sensitivity (%) 92 92 100 100 75
AM Specificity (%) 93 87 86 94 100
AM Kappa 0.67*** 0.72*** 0.63*** 0.64*** 0.85***
HR Accuracy (%) 96 92 90 96 100
HR PPV (%) 77 91 67 67 100
HR NPV (%) 98 92 93 98 100
HR Sensitivity (%) 77 78 57 67 100
HR Specificity (%) 98 97 95 98 100
HR Kappa 0.75*** 0.78*** 0.56*** 0.65*** 1.00***
Accuracy, positive (PPV) and negative (NPV) predictive values, sensitivity, specificity and Kappa of RTP-ASE using SPECT as method of reference.
CA, coronary area; LAD, left anterior descending coronary artery; LCx, left circumflex artery; RPD, right posterior descending coronary artery, *** 
= p < 0.001.Cardiovascular Ultrasound 2009, 7:19 http://www.cardiovascularultrasound.com/content/7/1/19
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analysis. Therefore, our results suggest that combined
analysis is superior for maintaining good feasibility as
well as good accuracy. It should be not that adenosine is
not an optimal stressor concerning wall motion analysis.
RTP-ASE is a highly available technique with possible
bedside accessibility, which makes it appealing for clinical
use, even in smaller hospitals with low access to angio-
graphic or scintigraphic techniques.
Study limitations
One obvious limitation is the subjectivity of RTP-ASE,
since it is based on visual estimation of both perfusion
and wall motion. Software tools for quantification of per-
fusion have been developed, which have shown promis-
ing results mainly in animal models [10,23,24] and a few
clinical studies [16,25-29]. These results indicate that
quantification of perfusion may soon be available for clin-
ical use, but there is still need for larger clinical studies to
evaluate feasibility. There are, however, need to improve
user-friendly dedicated software, need for off-line analysis
and the there is the additional cost of contrast agents.
It should be noted that this is an agreement study not an
accuracy study. One limitation of the present investiga-
tion is that we cannot separate perfusion defects caused by
macro-vascular or by micro-vascular disease because cor-
onary angiography was not available in these patients.
Further studies are needed to investigate the accuracy of
RTP-ASE, SPECT, and perhaps Cardiac-MRI versus
because coronary angiography.
Another limitation is that the RTP technique demands
skilful operators and interpreters with a substantial
amount of experience and knowledge in ultrasound phys-
ics, contrast agent characteristics and micro bubble behav-
ior when exposed to ultrasound. However, this ultrasonic
technique is still more available than other modalities
and is useful for bedside evaluation, which still makes
RTP-ASE an appealing and more accessible alternative.
The current study population consisted of patients with a
high-risk for cardiovascular disease and this data cannot
indiscriminately be used in low-risk patient-populations.
Furthermore, the study results may obviously not be
applicable to other types of populations with coronary
artery disease, such as patients with acute coronary syn-
drome.
Contrast safety
The U.S. Food and Drug Administration issued on Octo-
ber the 10th 2007 a "black box" warning for perflutren-
containing contrast agents, which caused considerable
Table 3: RTP-ASE angio-mode (AM) versus high resolution (HR) using solitary perfusion analysis.
Any CA
(n = 134)
Patient
(n = 39)
LAD
(n = 44)
LCx
(n = 42)
RPD
(n = 48)
AM Accuracy (%) 89 85 81 92 94
AM PPV(%) 48 71 43 50 60
AM N P V  ( % ) 9 9 9 61 0 0 1 0 09 8
AM Sensitivity (%) 92 92 100 100 75
AM Specificity (%) 89 81 78 91 96
AM Kappa 0.58*** 0.68*** 0.50*** 0.63*** 0.63***
HR Accuracy (%) 97 95 93 98 100
HR PPV (%) 80 90 67 100 100
HR NPV (%) 98 97 97 98 100
HR Sensitivity (%) 80 90 80 50 100
HR Specificity (%) 98 97 95 100 100
HR Kappa 0.78*** 0.87*** 0.69*** 0.66*** 1.00***
Accuracy, positive (PPV) and negative (NPV) predictive values, sensitivity, specificity and Kappa of RTP-ASE using SPECT as method of reference.
CA, coronary area; LAD, left anterior descending coronary artery; LCx, left circumflex artery; RPD, right posterior descending coronary artery, *** 
= p < 0.001.
Table 4: Agreement between RTP-ASE angio-mode and high 
resolution.
Any CA
(n = 150)
Patient
(n = 50)
LAD
(n = 50)
LCx
(n = 50)
RPD
(n = 50)
RTP + WM
Agreement (%) 92 80 82 94 98
Kappa 0.61*** 0.51*** 0.43** 0.64*** 0.85***
Sole RTP
Agreement (%) 88 77 78 91 94
Kappa 0.47*** 0.52** 0.43** 0.37** 0.54***
Combined perfusion and wall motion analysis, and using solitary 
perfusion analysis.
CA, coronary area; LAD, left anterior descending coronary artery; 
LCx, left circumflex artery; RPD, right posterior descending coronary 
artery; RTP, real time perfusion; WM, wall motion; ** = p < 0.01; *** 
= p < 0.001.Cardiovascular Ultrasound 2009, 7:19 http://www.cardiovascularultrasound.com/content/7/1/19
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controversies within the echocardiography community
[30]. This warning was later relaxed [31]. Three recent
large retrospective studies have disputed the suggestion
that using the current generation echo contrast would
pose a hazard to the patient [31-33]. Kusnetzky and co-
workers reported single-centre data on 18.671 consecutive
studies and found no increased acute mortality in patients
who had received a contrast agent [32]. Main et al.
reported data from a multicenter registry that included
4.300.966 consecutive patients [31]. Their finding was
that patients who had received echo contrast actually had
a lower mortality rate compared to those who had not
received contrast. Furthermore, Dolan et al. compared
23.659 patients from three U.S. medical centres who had
received echo contrast, at a rest examination, with 5.900
controls who had not received contrast, and found no
increased mortality or nonfatal myocardial infarct in
patients who had received contrast [33]. Dolan and co-
workers extended their analysis and compared 10.788
patients who had undergone stress echocardiography
(DSE or exercise stress echocardiography) and received
contrast with 15.989 who had not received contrast. No
A graph of accuracy between different modalities of RTP-ASE versus SPECT Figure 2
A graph of accuracy between different modalities of RTP-ASE versus SPECT. Left anterior descending (LAD), left 
circumflex (LCx) and right coronary artery (RCA). Angio-mode (AM), high resolution (HR) and wall motion (WM).
Table 5: Non-interpretable coronary areas for RTP-ASE angio-mode (AM) and high resolution (HR).
Any CA
(n = 150)
Patient
(n = 50)
LAD
(n = 50)
LCx
(n = 50)
RPD
(n = 50)
AM RTP + WM (%) 0 0 0 0 0
AM Sole RTP (%) 13.3 22.0 16.0 24.0 0
HR RTP + WM (%) 0 0 0 0 0
HR Sole RTP (%) 10.7 22.0 12.0 16.0 4.0
Combined perfusion and wall motion analysis, and solitary perfusion analysis.
CA, coronary area; LAD, left anterior descending coronary artery; LCx, left circumflex artery; RPD, right posterior descending coronary artery; 
RTP, real time perfusion; WM, wall motion.Cardiovascular Ultrasound 2009, 7:19 http://www.cardiovascularultrasound.com/content/7/1/19
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increased mortality or nonfatal myocardial infarct in
patients who had received contrast could be found also in
this cohort. These studies clearly show that using echo
contrast in stable patients does not pose a significant risk.
This knowledge must be weighted against the hazards of a
non-diagnostic echocardiography examination, and the
potential risks accompanied by alternative tests. Finally,
cost effectiveness remains to be demonstrated and real
additive value of routine use of echo contrast in every
patient that undergo stress echocardiography.
Conclusion
The present investigation compared two different types
RTP power modulation ASE. Both techniques showed
highly significant agreements for the detection of reversi-
ble myocardial ischemia, using SPECT as method of refer-
ence. There was no significant difference between AM and
HR in correctly detecting myocardial ischemia as judged
by SPECT. This suggests that data derived from different
techniques for RTP-ASE are reasonably interchangeable.
When using the combined perfusion and wall motion
interpretation, feasibility was higher, with almost no non-
interpretable segments. Therefore, our results also suggest
that combined analysis of perfusion and wall motion pro-
vides superior feasibility and accuracy of RTP-ASE.
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